The Patent Finder

Terms ending in 2027

Amgen Inc.

Every in-force patent on Amgen Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,100,124Antibodies Directed to HER-3 and Uses Thereof
In force
 · High confidence
Daiichi Sankyo Europe GmbHIn forceHigh confidence
US 11,267,900Antibodies Directed to HER-3 and Uses Thereof
In force
 · Medium confidence
Amgen Inc.,In forceMedium confidence
US 9,988,462Material and Methods for Treating or Preventing HER-3 Associated Diseases
In force
 · High confidence
Daiichi Sankyo Europe GmbHIn forceHigh confidence
US 8,614,292An isolated protein comprising an activin type IIB5 receptor polypeptide and uses thereof
In force
 · High confidence
Amgen, Inc.In forceHigh confidence
US 7,514,566Thiazole Compounds and Methods of Use
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US RE45,847Antibodies to Madcam
In force
 · Low confidence
Amgen Fremont Inc.In forceLow confidence
US 8,946,151Method of treating Parkinson's disease in humans by convection-enhanced infusion of glial cell-line derived neurotrophic factor to the putamen
In force
 · Medium confidence
Northern Bristol N.H.S. Trust Frenchay HospitalIn forceMedium confidence
US 7,928,205Methods for Refolding of Recombinant Antibodies
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,304,387Therapeutic Formulations of Keratinocyte Growth Factor
In force
 · High confidence
Swedish Orphan Biovitrum AB (publ)In forceHigh confidence
US 10,072,090Human Anti-B7RP1 Neutralizing Antibodies
In force
 · High confidence
Amgen Inc.In forceHigh confidence
47 more term ends in 2027 · Pro
10 of 57 patents shown. Soonest term end first, then patent number.
Pro members see all 57, all of them expiring within the 18 months from Nov 21, 2026.
Upgrade to Pro
42 of these are in force and held by Amgen Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited